Great for clients focused on energy, metabolism, and body wellness
Numerous gut- and brain-derived peptides exert potent anorectic or orexigenic effects, often with effect sizes comparable to or exceeding those of GLP-1 in preclinical models
In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg
Recommended taking 20 ml L-Carnitine Liquid daily 20 minutes before the training and on days without training directly after getting up
Who Should and Shouldn't Combine These Compounds: Clinical Eligibility The combination may be most appropriate for patients with PCOS, metabolic syndrome, or insulin resistance who are using tirzepatide for weight management or glycemic control
Experiments were performed with randomly allocated, size-matched islets
